Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Audit on the Managment in Assiut University Children Hospital

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03281863
Recruitment Status : Unknown
Verified September 2017 by Patricia reda hanna, Assiut University.
Recruitment status was:  Not yet recruiting
First Posted : September 13, 2017
Last Update Posted : September 15, 2017
Sponsor:
Information provided by (Responsible Party):
Patricia reda hanna, Assiut University

Tracking Information
First Submitted Date August 29, 2017
First Posted Date September 13, 2017
Last Update Posted Date September 15, 2017
Estimated Study Start Date October 1, 2017
Estimated Primary Completion Date September 29, 2018   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: September 11, 2017)
laboratory investigations (ASOt , ESR . CRP) [ Time Frame: One year from October 2017 to september 2018 ]
laboratory investigations that measure the inflammation process will be used and the target that the ASOt not increase 1/400
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures
 (submitted: September 11, 2017)
clinical measures [ Time Frame: One year from October 2017 to september 2018 ]
improvement of arthritis if found
Original Secondary Outcome Measures Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Clinical Audit on the Managment in Assiut University Children Hospital
Official Title Clinical Audit on the Managment of Rheumatic Fever in Assiut University Children Hospital
Brief Summary clinical audit on the Managment of rheumatic fever in assiut university children hospital.
Detailed Description

Acute rheumatic fever,an auto immune response to Group A streptococcus infection of the upper respiratory tract,may result in carditis.when the inflammation leads to permenant damage of the valves the individual has rheumatic heart disease.

Recurrences of rheumatic fever are likely in the absence of preventive measures and may cause further cardiac valve and muscle damage,leading to heart failure,stroke and premature death.bacterial endocarditis is also a complication.

Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Probability Sample
Study Population Clinical audit on the managment of rheumatic fever in assiut university children hospital
Condition Rheumatic Fever
Intervention Diagnostic Test: C reactive protein, anti streptolysin o antibody test ,erythrocyte sedimentation rate
Throat culture to detect the causative organism
Other Name: Throat culture
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Unknown status
Estimated Enrollment
 (submitted: September 11, 2017)
100
Original Estimated Enrollment Same as current
Estimated Study Completion Date September 29, 2018
Estimated Primary Completion Date September 29, 2018   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • patients with confirmed diagnosis of rheumatic fever based on laboratory investigations.

Exclusion Criteria:

  • No
Sex/Gender
Sexes Eligible for Study: All
Ages 5 Years to 15 Years   (Child)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Not Provided
Removed Location Countries  
 
Administrative Information
NCT Number NCT03281863
Other Study ID Numbers AssiutU71516
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement
Plan to Share IPD: No
Responsible Party Patricia reda hanna, Assiut University
Study Sponsor Assiut University
Collaborators Not Provided
Investigators Not Provided
PRS Account Assiut University
Verification Date September 2017